NightOwl

DEVICE5 trials

Sponsors

Ectosense NV, Herlev and Gentofte Hospital, Steno Diabetes Center Greenland

Conditions

Diabetes Mellitus, Type 2Diabetic NeuropathiesDiabetic RetinopathyMODYObesity, MorbidObstructive Sleep ApneaPulse Oximeter CalibrationSleep Apnea

Unknown Phase

NightOwl Pulse Oximeter Calibration Study

Ectosense NVPulse Oximeter Calibration

Start: 2018-12-14End: 2020-04-14Target: 30Updated: 2019-03-21

A Validation Study of the NightOwl PAT-based Home Sleep Apnea Test

CompletedNCT04191668

Ectosense NVSleep Apnea

Start: 2019-12-02End: 2020-02-01Updated: 2021-03-30

DANish Patients With Atrial Fibrillation and Sleep Apnea Prevalence by Night Owl

CompletedNCT04760002

Herlev and Gentofte HospitalObstructive Sleep Apnea

Start: 2021-01-25End: 2023-01-01Updated: 2023-03-03

A Validation Study of the NightOwl Home Sleep Apnea Test

Ectosense NVSleep Apnea

Start: 2021-03-20End: 2022-09-10Target: 100Updated: 2022-09-06

Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland

RecruitingNCT06264427

Steno Diabetes Center GreenlandDiabetes Mellitus, Type 2, Diabetic Neuropathies, Diabetic Retinopathy +3

Start: 2022-07-15End: 2026-12-31Target: 1000Updated: 2024-02-20

Related Papers

Context-aware analysis enhances autoscoring accuracy of home sleep apnea testing.

2025-05-01

Protocol for detecting unrecognized sleep apnea in patients with atrial fibrillation by a home-monitoring device: the DAN-APNO study

BMC Cardiovascular Disorders2022-01-085 citations